Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IND for satraplatin transferred to NeoOncoRx

Jan. 14, 2002

Chiron obtains option to Procyon prostate cancer technology

Jan. 14, 2002

Patent coverage obtained by NeoPharm for a NeoLipid antisense compound

Jan. 14, 2002

FDA advisory committee delays review of Bexxar

Jan. 14, 2002

Genta files IND for gallium nitrate in NHL

Jan. 11, 2002

Onyvax initiates phase II trial of Onyvax P in prostate cancer

Jan. 11, 2002

Two phase II trials of Neotrofin initiated in chemotherapy-induced neuropathy

Jan. 10, 2002

DGI BioTechnologies and Novo Nordisk enter collaboration for cancer agents

Jan. 10, 2002

Antisense oligonucleotide targeting Ki-ras as an approach to colorectal cancer

Jan. 10, 2002

Endothelial cell-specific inhibition of protein synthesis demonstrated for tumstatin

Jan. 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...